|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/44 | (2006.01) |
| (11) | Number of the document | 3648768 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18750243.0 |
| Date of filing the European patent application | 2018-07-04 | |
| (97) | Date of publication of the European application | 2020-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/FR2018/000188 |
| Date | 2018-07-04 |
| (87) | Number | WO 2019/008239 |
| Date | 2019-01-10 |
| (30) | Number | Date | Country code |
| 1700713 | 2017-07-05 | FR |
| (72) |
JANIN, Eric , FR
|
| (73) |
ERICARE ,
9 avenue de Lavaur, 31500 Toulouse,
FR
|
| (54) | IMÉGLIMINE POUR LA PRÉVENTION ET/OU LE TRAITEMENT DU CARCINOME HÉPATOCELLULAIRE |
| IMEGLIMIN FOR PREVENTING AND/OR TREATING HEPATOCELLULAR CARCINOMA |